Adam J. Townsend, Chief Commercial Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 10,000 shares at $58.54 ($368K) on 2022-11-03, disclosed to the SEC on 2022-11-07.
Open-market sale of $368k APLS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.09 | 5,000 | $75K | 20.5% |
| 2 | $58.54 | 5,000 | $293K | 79.5% |
| Total | $36.81 avg | 10,000 | $368K | 100% |
| Filing → |
| APLS | SELL | 2025-01-21 | $132K | — | Filing → |
| APLS | SELL | 2025-01-14 | $154K | — | Filing → |
| APLS | SELL | 2024-02-13 | $156K | — | Filing → |